Efikasi dan Tolerabilitas Karbamazepin untuk Nyeri Neuropati Diabetik

Hanik Badriyah Hidayati*
*Staff Pengajar Departemen Neurologi FK UNAIR – RSUD Dr. Soetomo Surabaya
Penulis Korespondensi: Hanik Badriyah Hidyati (hanikhidayati@fk.unair.ac.id)

Abstrak

Neuropati perifer merupakan salah satu alasan paling sering pasien dirujuk ke klinik neurologi. Neuropati diabetik, salah satu neuropati perifer, merupakan penyebab neuropati tersering di dunia sehingga masih merupakan masalah besar dunia. Nyeri neuropati diabetik (NND) merupakan komplikasi umum dari diabetes baik diabetes tipe 1 maupun tipe 2. NND mempengaruhi kualitas hidup pasien secara substansial akibat dari kurang tidur, kelelahan konstan, kesulitan mempertahankan konsentrasi secara penuh, gangguan melakukan aktivitas harian, gangguan mood, depresi dan ansietas. Karbamazepin merupakan salah satu terapi nyeri neuropati. Artikel ini menjelaskan efikasi dan tolerabilitas karbamazepin untuk nyeri neuropati diabetik.

Kata kunci: efikasi, nyeri neuropati diabetik, tolerabilitas, karbamazepin.

Daftar Pustaka

  1. Hidayati H, Kustriyani A. Paracetamol, migraine, and medication over use headache (MOH). JPHV (J pain, Vertigo Headache). 2020;1(2):42-7. doi:10.21776/ub.jphv.2020.001.02.5
  2. Haroutounian S, Finnerup B, Pharmacotherapy P. Recommendations for pharmacologic therapy of neuropathic pain. 4th Edi. Elsevier; 2018. doi:10.1016/B978-0-323-40196-8.00050-4
  3. Hidayati HB, Machfoed MH, Kuntoro, Subadi I, Khaerunnisa S, Widjiati. Increase in the glutamate transporter 1 and time withdrawal latency following wet cupping therapy in chronic constriction injury in rats. Anaesthesia, Pain Intensive Care. 2021;25(1):48-54. doi:10.35975/apic.v25i1.1441
  4. Hidayati H. Carbamzepine as a pain treatment of trigeminal neuralgia. JPHV (J Pain, Vertigo Headache). 2020;1(2):37-41. doi:10.21776/ub.jphv.2020.001.02.4
  5. Chandra Imelda N, Baktir F, Hidayati HB, Basuki M. Updates in the management of guillain barre syndrome. Anesth, Pain Intensive Care. 2018;22(1):S54-S57. doi:10.35975/apic/v22i1.1102
  6. Rana NRE, Awalia, Hernaningsih Y, Hidayati HB. Manifestasi neuropsikiatrik pada lupus eritematosus sistemik di RSUD Dr. Soetomo Surabaya. Neurona. 2019;36(4):293-98.
  7. Ilmanita D, Hidayati HB. Tricyclic antidepressants in chronic low back pain: A review. J Islamic Pharm. 2019;4(2):21-6. doi:10.18860/jip.v4i2.8217
  8. Hidayati HB, Machfoed HM, Kutoro, Soetojo, Santoso B, Utomo B. Bekam sebagai terapi alternatif untuk nyeri (cupping as a pain alternative). Neurona.2019;36(2):148-56.
  9. Setianti AR, Hidayati HB. Effectiveness of triamcinolone and lidocaine in patient with piriformis syndrome: a case series. Pharmaceutical Journal indonesia. 2019;5(1):31-5.
  10. Kadarusman TA, Badriyah Hidayati H, Sugianto P. Profil of analgesic drugs administration for carpal tunnel syndrome in Dr.Soetomo general hospital surabaya. JUXTA. 2019;10(1):1-4. doi:10.20473/juxta.V10I12019.1-4
  11. Kurniawati N, Suharjanti I, Hamdan M, Rahardjo JE, Ardiansyah D, Hidayati HB. Efficacy of acetaminophen plus amitriptyline compared to acetaminophen to reduce pain intensity in nonspecific chronic lower back pain. Indian J Forensic Med Toxicol. 2020;14(2):1819-25. doi:10.37506/ijfmt.v14i2.3202
  12. Dureja GP, Iyer RN, Das G, Ahdal J, Narang P. Evidence and consensus recommendations for the pharmacological management of pain in India. J Pain Res. 2017;10:709-36. doi:10.2147/JPR.S128655
  13. Saeed T, Nasrullah M, Ghafoor A, Shahid R, Islam N, Khattak MU, et al. Efficacy and tolerability of carbamazepine for the treatment of painful diabetic neuropathy in adults : a 12-week , open-label , multicenter study. Int J Gen Med. 2014;4(7):339-43.
  14. Hidayati HB, Sugianto P, Khotib J, Ardianto C, Kuntoro, Machfoed MH. Pengukuran tingkah laku pada model nyeri neuropatik perifier: Tikus dengan CCI (chronic constriction injury). Neurona. 2018;35(3):209-14.
  15. Nickel FT, Seifert F, Lanz S, Maihöfner C. Mechanisms of neuropathic pain. Eur Neuropsychopharmacol. 2012;22(2):81-91. doi:10.1016/j.euroneuro.2011.05.005
  16. Cohen K, Shinkazh N, Frank J, Israel I, Fellner C. Pharmacological Treatment Of Diabetic Peripheral Neuropathy. P T. 2015;40(6):372-88.
  17. Schreiber AK, Nones CFM, Ceis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes. 2015;6(3):432-44. doi:10.4239/wjd.v6.i3.432
  18. Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, et al. Diabetic peripheral neuropathy : Epidemiology , diagnosis , and pharmacotherapy. Clin Ther. 2018;40(6):828-49. doi:10.1016/j.clinthera.2018.04.001
  19. Tesfaye S. Neuropathy in diabetes. Medicine. 2015;43(1):26-32. doi:10.1016/j.mpmed.2014.10.013
  20. Lindsay TJ, Rodgers BC, Savath V, Hettinger K. Treating diabetic peripheral neuropathic pain. Am Fam Physician. 2010;82(2):151-8.
  21. Marcum ZA, Duncan NA, Makris UE. Pharmacotherapies in geriatric chronic pain management. Clin Geriatr Med. 2016;32(4):705-24. doi:10.1016/j.cger.2016.06.007
  22. Hanewinckel R, Ikram MA, Doorn PA Van. Peripheral neuropathies. Vol 138. 1st ed. Elsevier BV. 2016. doi:10.1016/B978-0-12-802973-2.00015-X
  23. Dimachkie MM, Barohn RJ. Peripheral neuropathies. Vol 2. Elsevier Ltd. 2015. 857-88p. doi:10.1016/B978-0-12-802653-3.00104-4
  24. Chill V, McCorry D, Soryal I, Rajabally YA. Newer anti-epileptic drugs , vitamin status and neuropathy : A cross-sectional analysis. Rev Neurol (Paris). 2017:173(1-2):62-6. doi:10.1016/j.neurol.2016.09.008
  25. Petropoulos IN, Javed S, Azmi S, Khan A, Ponirakis G, Malik RA. Diabetic neuropathy and painful diabetic neuropathy in the Middle East and North Africa ( MENA ) region : Much work needs to be done. J Taibah Univ Med Sci. 2016;11(4):284-94. doi:10.1016/j.jtumed.2016.06.002
  26. Rosen JD, Fostini AC, Yosipovitch G. Diagnosis and management of neuropathic itch. Dermatol Clin. 2018. doi:10.1016/j.det.2018;36(3):213-24.02.005
  27. Lee JTC, Shanina I, Chu YN, Horwitz MS, Johnson JD. Carbamazepine , a beta-cell protecting drug , reduces type 1 diabetes incidence in NOD mice. Sci Rep. 2018;15(1):1-9. doi:10.1038/s41598-018-23026-w
  28. 28. Montero AA, Carnerero CIS, García CG. Revista Española de Anestesiología y Reanimación Emerging therapies in clinical development and new contributions for neuropathic pain ଝ. Rev Española Anestesiol Y Reanim (English ed). 2019;66(6):324-34. doi:10.1016/j.redare.2019.02.004
  29. Vinik A, Ullal J, Parson HK, Casellini CM. Diabetic neuropathies : clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab. 2006;2(5):269-81. doi:10.1038/ncpendmet0142
  30. Montero AA, Carnerero CIS, García CG. Revista Española de Anestesiología y Reanimación Emerging therapies in clinical development and new contributions for neuropathic pain ଝ. Rev Española Anestesiol Y Reanim (English ed). 2019;66(6):324-34. doi:10.1016/j.redare.2019.02.004
  31. Beckett RD, Klemke N, Bessesen M, Ray SD. Antiepileptics. Side Eff Drugs Annu. 2017;39:91-106. doi:10.1016/bs.seda.2017.07.009
  32. Spoelhof B, Frendak L, Kiehle N, Martinelli A, Lara LR. Antiepileptics : Side effects of drugs annual. Elsevier B V. 2016;38(16):55-70. doi:10.1016/bs.seda.2016.07.013